BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30244192)

  • 1. Cushing Syndrome Induced by Topical Corticosteroids for the Treatment of Lichen Sclerosus.
    Notay M; Fazel N; Awasthi S
    J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):83-85. PubMed ID: 30244192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Too much of a good thing? Iatrogenic Cushing syndrome secondary to excessive topical steroid use in lichen sclerosus.
    Psomadakis C; Tweddell R; Lewis F
    Clin Exp Dermatol; 2023 Mar; 48(4):429-430. PubMed ID: 36763764
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment.
    Matsumoto Y; Yamamoto T; Isobe T; Kusunoki T; Tsuboi R
    J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
    Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
    J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's syndrome induced by high-potency topical corticosteroids.
    Demirsoy EO; Bilen N; Aktürk AS; Kocaoğlu Ö; Mutlu GY
    Int J Dermatol; 2014 Jan; 53(1):e20-2. PubMed ID: 22591336
    [No Abstract]   [Full Text] [Related]  

  • 7. An infantile Cushing syndrome due to misuse of topical steroid.
    Siklar Z; Bostanci I; Atli O; Dallar Y
    Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic Cushing's syndrome and topical steroid therapy: case series and review of the literature.
    Decani S; Federighi V; Baruzzi E; Sardella A; Lodi G
    J Dermatolog Treat; 2014 Dec; 25(6):495-500. PubMed ID: 23210698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children.
    Casey GA; Cooper SM; Powell JJ
    Clin Exp Dermatol; 2015 Apr; 40(3):289-92. PubMed ID: 25477189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous Cushing syndrome due to misuse of potent topical steroid.
    Özgüç Çömlek F; Örüm S; Aydın S; Tütüncüler F
    Pediatr Dermatol; 2018 Mar; 35(2):e121-e123. PubMed ID: 29315782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical steroid-induced Cushing syndrome.
    Al-Khenaizan S; Al Alwan I
    Ann Saudi Med; 2008; 28(4):300-2. PubMed ID: 18596396
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus - A double-blind randomized phase II pilot study.
    Günthert AR; Limacher A; Beltraminelli H; Krause E; Mueller MD; Trelle S; Bobos P; Jüni P
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():88-95. PubMed ID: 35290878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic Cushing's syndrome due to overuse of topical steroid in the diaper area.
    Ozdemir A; Bas VN
    J Trop Pediatr; 2014 Oct; 60(5):404-6. PubMed ID: 25016382
    [No Abstract]   [Full Text] [Related]  

  • 14. Pituitary-adrenal axis suppression due to topical steroid administration in an infant.
    Atabek ME; Pirgon O; Unal E
    Pediatr Int; 2007 Apr; 49(2):242-4. PubMed ID: 17445047
    [No Abstract]   [Full Text] [Related]  

  • 15. Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area.
    Semiz S; Balci YI; Ergin S; Candemir M; Polat A
    Pediatr Dermatol; 2008; 25(5):544-7. PubMed ID: 18950396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Clobetasol: An Overlooked Cause of Cushing Syndrome.
    Ghirardo S; De Nardi L; Tommasini A; Barbi E; Tornese G
    Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2300-2302. PubMed ID: 33902425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability.
    Virgili A; Borghi A; Toni G; Minghetti S; Corazza M
    Br J Dermatol; 2014 Aug; 171(2):388-96. PubMed ID: 24641522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing syndrome caused by topical corticosteroid: a case report.
    Gen R; Akbay E; Sezer K
    Am J Med Sci; 2007 Mar; 333(3):173-4. PubMed ID: 17496736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous Cushing syndrome: a lesson of diaper rash cream.
    Ho CW; Loke KY; Lim YY; Lee YS
    Horm Res Paediatr; 2014; 82(6):415-8. PubMed ID: 25300899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of an ultrapotent topical steroid for the treatment of vulval lichen sclerosus is safe.
    Kai A; Lewis F
    J Obstet Gynaecol; 2016; 36(2):276-7. PubMed ID: 26491985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.